Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (2554)	11/17/1997 2:00:00 PM
From: Gene Voss	Read Replies (2) \| Respond to of 23519

Cacaito: If oral phentolamine is approved I'll know the era of snake oil has returned.With the rush to be a part of the ED market all kinds of junk science is being hyped.You would expect the FDA to view these various therapies objectively with a sense of caution and I'm encouraged that they will.The approval of any agent capable of causing harm,especially in this setting is unforgiveable. I'm working on finding out the formula Pfizer used in their placebo,with an efficacy of 40% I think a very succesful product could be developed. GV

To: Cacaito who wrote (2554)	11/17/1997 4:34:00 PM
From: RT	Read Replies (2) \| Respond to of 23519

Cacaito, Yes ur re, Vivus's PR machine is still broke dick. Perhaps they feel our stock has not gone low enough. Whatever the reason for their vow of silence I think it's inexcusable.. Perhaps those di*kless wonders will someday realize they have investors who have invested heavily into this company and expect a competant management team. I for one do not need another investment write off. Dr. Bond , Brad, anybody have any positive news to share. The market is up 125 points and Vivus is down. WHY OH WHY ??? RT